Skip to main content

MediciNova Insider Trades

+0.05 (+1.22 %)
(As of 05/18/2021 04:39 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume209,303 shs
Average Volume704,553 shs
Market Capitalization$201.90 million
P/E RatioN/A
Dividend YieldN/A

Insider Trades

MediciNova (NASDAQ:MNOV) Insider Buying and Selling Activity

Insider Ownership Percentage: 16.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $23,199.60

Insider Buying and Selling by Quarter

MediciNova (NASDAQ MNOV) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/11/2021Hideki NagaoDirectorSell2,354$7.40$17,419.6012,646  
9/15/2020Hideki NagaoDirectorSell1,000$5.78$5,780.0015,000  
3/13/2020Kazuko MatsudaInsiderBuy2,000$3.62$7,240.00  
3/12/2020Yuichi IwakiCEOBuy20,000$3.10$62,000.00  
8/21/2017Yoshio IshizakaDirectorBuy5,000$5.17$25,850.005,000  
5/15/2017Yutaka KobayashiDirectorBuy1,000$5.60$5,600.0081,800  
5/12/2017Yutaka KobayashiDirectorBuy24,000$5.62$134,880.0081,800  
9/15/2016Yutaka KobayashiDirectorBuy11,800$6.44$75,992.0081,800  
9/9/2016Yutaka KobayashiDirectorBuy10,000$6.67$66,700.0070,000  
7/5/2016Geoffrey ObrienVPSell3,300$8.00$26,400.008,300  
12/10/2014Yutaka KobayashiDirectorBuy12,000$3.54$42,480.00  
11/26/2014Yutaka KobayashiDirectorBuy10,000$3.07$30,700.00  
11/20/2014Yutaka KobayashiDirectorBuy13,000$3.19$41,470.00  
11/19/2014Yoshio IshizakaDirectorBuy5,000$2.86$14,300.00  
9/11/2014Yutaka KobayashiDirectorBuy10,000$2.95$29,500.00  
9/3/2014Yutaka KobayashiDirectorBuy15,000$2.66$39,900.00  
12/12/2013Tatsuo IzumiDirectorSell71,270$2.10$149,667.00  
11/18/2013Tatsuo IzumiDirectorBuy1,270$2.21$2,806.70  
5/21/2013Arlene MorrisDirectorSell8,800$3.28$28,864.00  
5/13/2013Tatsuo IzumiDirectorBuy158,730$3.15$499,999.50  
(Data available from 1/1/2013 forward)
This page was last updated on 5/18/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.